• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VDAC2-BAK 复合物中的关键残基可以作为靶点来调节细胞凋亡。

Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosis.

机构信息

Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Australia.

Department of Medical Biology, University of Melbourne, Parkville, Melbourne, Australia.

出版信息

PLoS Biol. 2024 May 2;22(5):e3002617. doi: 10.1371/journal.pbio.3002617. eCollection 2024 May.

DOI:10.1371/journal.pbio.3002617
PMID:38696533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11098506/
Abstract

BAK and BAX execute intrinsic apoptosis by permeabilising the mitochondrial outer membrane. Their activity is regulated through interactions with pro-survival BCL-2 family proteins and with non-BCL-2 proteins including the mitochondrial channel protein VDAC2. VDAC2 is important for bringing both BAK and BAX to mitochondria where they execute their apoptotic function. Despite this important function in apoptosis, while interactions with pro-survival family members are well characterised and have culminated in the development of drugs that target these interfaces to induce cancer cell apoptosis, the interaction between BAK and VDAC2 remains largely undefined. Deep scanning mutagenesis coupled with cysteine linkage identified key residues in the interaction between BAK and VDAC2. Obstructive labelling of specific residues in the BH3 domain or hydrophobic groove of BAK disrupted this interaction. Conversely, mutating specific residues in a cytosol-exposed region of VDAC2 stabilised the interaction with BAK and inhibited BAK apoptotic activity. Thus, this VDAC2-BAK interaction site can potentially be targeted to either inhibit BAK-mediated apoptosis in scenarios where excessive apoptosis contributes to disease or to promote BAK-mediated apoptosis for cancer therapy.

摘要

BAK 和 BAX 通过使线粒体外膜通透来执行内在凋亡。它们的活性通过与生存促进 BCL-2 家族蛋白的相互作用以及与非 BCL-2 蛋白(包括线粒体通道蛋白 VDAC2)的相互作用来调节。VDAC2 对于将 BAK 和 BAX 带到线粒体中使其执行凋亡功能非常重要。尽管在凋亡中具有重要功能,但尽管与生存促进家族成员的相互作用已经得到很好的描述,并最终开发出靶向这些界面以诱导癌细胞凋亡的药物,但 BAK 和 VDAC2 之间的相互作用在很大程度上仍未得到定义。深扫描诱变结合半胱氨酸连接鉴定了 BAK 和 VDAC2 之间相互作用的关键残基。BAK 的 BH3 结构域或疏水性槽中特定残基的阻塞标记破坏了这种相互作用。相反,突变 VDAC2 细胞质暴露区域中的特定残基稳定了与 BAK 的相互作用并抑制了 BAK 的凋亡活性。因此,这个 VDAC2-BAK 相互作用位点可以潜在地靶向抑制在过度凋亡导致疾病的情况下 BAK 介导的凋亡,或者促进 BAK 介导的凋亡用于癌症治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/53264e560cf3/pbio.3002617.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/73e9f022b4e9/pbio.3002617.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/009db3084b87/pbio.3002617.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/608136362968/pbio.3002617.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/5248c5dbaae4/pbio.3002617.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/fba3b626653e/pbio.3002617.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/53264e560cf3/pbio.3002617.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/73e9f022b4e9/pbio.3002617.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/009db3084b87/pbio.3002617.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/608136362968/pbio.3002617.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/5248c5dbaae4/pbio.3002617.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/fba3b626653e/pbio.3002617.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f669/11098506/53264e560cf3/pbio.3002617.g006.jpg

相似文献

1
Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosis.VDAC2-BAK 复合物中的关键残基可以作为靶点来调节细胞凋亡。
PLoS Biol. 2024 May 2;22(5):e3002617. doi: 10.1371/journal.pbio.3002617. eCollection 2024 May.
2
Bax targets mitochondria by distinct mechanisms before or during apoptotic cell death: a requirement for VDAC2 or Bak for efficient Bax apoptotic function.在凋亡性细胞死亡之前或期间,Bax通过不同机制作用于线粒体:高效发挥Bax凋亡功能需要VDAC2或Bak。
Cell Death Differ. 2014 Dec;21(12):1925-35. doi: 10.1038/cdd.2014.119. Epub 2014 Aug 22.
3
Structure-based modeling of turnover of Bcl-2 family proteins bound to voltage-dependent anion channel 2 (VDAC2): Implications for the mechanisms of proapoptotic activation of Bak and Bax in vivo.基于结构的 Bcl-2 家族蛋白与电压依赖性阴离子通道 2(VDAC2)结合物周转率建模:对 Bak 和 Bax 在体内促凋亡激活机制的影响。
Comput Biol Chem. 2020 Apr;85:107203. doi: 10.1016/j.compbiolchem.2020.107203. Epub 2020 Jan 13.
4
Assembly of the Bak apoptotic pore: a critical role for the Bak protein α6 helix in the multimerization of homodimers during apoptosis.Bak 凋亡孔的组装:Bak 蛋白 α6 螺旋在凋亡过程中同源二聚体的多聚化中的关键作用。
J Biol Chem. 2013 Sep 6;288(36):26027-26038. doi: 10.1074/jbc.M113.490094. Epub 2013 Jul 26.
5
Disruption of the VDAC2-Bak interaction by Bcl-x(S) mediates efficient induction of apoptosis in melanoma cells.Bcl-x(S) 通过破坏 VDAC2-Bak 相互作用介导黑素瘤细胞中凋亡的有效诱导。
Cell Death Differ. 2012 Dec;19(12):1928-38. doi: 10.1038/cdd.2012.71. Epub 2012 Jun 15.
6
Motifs of VDAC2 required for mitochondrial Bak import and tBid-induced apoptosis.线粒体Bak导入及tBid诱导凋亡所需的VDAC2基序。
Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):E5590-9. doi: 10.1073/pnas.1510574112. Epub 2015 Sep 28.
7
VDAC2 is required for truncated BID-induced mitochondrial apoptosis by recruiting BAK to the mitochondria.VDAC2 通过将 BAK 招募到线粒体中来介导截断型 BID 诱导的线粒体凋亡。
EMBO Rep. 2009 Dec;10(12):1341-7. doi: 10.1038/embor.2009.219. Epub 2009 Oct 9.
8
VDAC2 inhibits BAK activation and mitochondrial apoptosis.电压依赖性阴离子通道蛋白2抑制BAK激活和线粒体凋亡。
Science. 2003 Jul 25;301(5632):513-7. doi: 10.1126/science.1083995.
9
VDAC2 enables BAX to mediate apoptosis and limit tumor development.VDAC2 使 BAX 能够介导细胞凋亡并限制肿瘤的发展。
Nat Commun. 2018 Nov 26;9(1):4976. doi: 10.1038/s41467-018-07309-4.
10
Requirement of voltage-dependent anion channel 2 for pro-apoptotic activity of Bax.Bax促凋亡活性对电压依赖性阴离子通道2的需求。
Oncogene. 2009 Oct 8;28(40):3563-72. doi: 10.1038/onc.2009.213. Epub 2009 Jul 20.

引用本文的文献

1
VDAC2 loss elicits tumour destruction and inflammation for cancer therapy.VDAC2缺失引发肿瘤破坏和炎症以用于癌症治疗。
Nature. 2025 Apr;640(8060):1062-1071. doi: 10.1038/s41586-025-08732-6. Epub 2025 Mar 19.
2
Differential regulation of BAX and BAK apoptotic activity revealed by small molecules.小分子揭示的BAX和BAK凋亡活性的差异调节
Sci Adv. 2025 Mar 7;11(10):eadr8146. doi: 10.1126/sciadv.adr8146. Epub 2025 Mar 5.
3
Mendelian randomization analysis and molecular mechanism study of childhood asthma and obstructive sleep apnea.

本文引用的文献

1
Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity.p53/BCL-2 复合物的结构提示了 p53 拮抗 BCL-2 活性的机制。
Nat Commun. 2023 Jul 18;14(1):4300. doi: 10.1038/s41467-023-40087-2.
2
Mechanisms of BCL-2 family proteins in mitochondrial apoptosis.BCL-2 家族蛋白在线粒体凋亡中的作用机制。
Nat Rev Mol Cell Biol. 2023 Oct;24(10):732-748. doi: 10.1038/s41580-023-00629-4. Epub 2023 Jul 12.
3
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
儿童哮喘与阻塞性睡眠呼吸暂停的孟德尔随机化分析及分子机制研究
Hum Genet. 2025 Apr;144(4):443-461. doi: 10.1007/s00439-025-02734-0. Epub 2025 Mar 3.
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
4
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X Inhibitor.A-1331852的发现,一种首创的、强效的、口服生物可利用的BCL-X抑制剂。
ACS Med Chem Lett. 2020 Mar 30;11(10):1829-1836. doi: 10.1021/acsmedchemlett.9b00568. eCollection 2020 Oct 8.
5
Improved protein structure prediction using potentials from deep learning.利用深度学习势进行蛋白质结构预测的改进。
Nature. 2020 Jan;577(7792):706-710. doi: 10.1038/s41586-019-1923-7. Epub 2020 Jan 15.
6
A small molecule interacts with VDAC2 to block mouse BAK-driven apoptosis.一种小分子与 VDAC2 相互作用,以阻断小鼠 BAK 驱动的细胞凋亡。
Nat Chem Biol. 2019 Nov;15(11):1057-1066. doi: 10.1038/s41589-019-0365-8. Epub 2019 Oct 7.
7
VDAC2 enables BAX to mediate apoptosis and limit tumor development.VDAC2 使 BAX 能够介导细胞凋亡并限制肿瘤的发展。
Nat Commun. 2018 Nov 26;9(1):4976. doi: 10.1038/s41467-018-07309-4.
8
Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based Design.通过基于结构的设计将 Bim-BH3 从 Bak 的激活剂转换为抑制剂。
Mol Cell. 2017 Nov 16;68(4):659-672.e9. doi: 10.1016/j.molcel.2017.11.001.
9
BAK α6 permits activation by BH3-only proteins and homooligomerization via the canonical hydrophobic groove.BAKα6 通过 BH3-仅有蛋白的激活和通过规范的疏水性沟槽的同源寡聚化来允许激活。
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):7629-7634. doi: 10.1073/pnas.1702453114. Epub 2017 Jul 3.
10
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.MCL1 抑制剂 S63845 在多种癌症模型中具有良好的耐受性和疗效。
Nature. 2016 Oct 27;538(7626):477-482. doi: 10.1038/nature19830. Epub 2016 Oct 19.